Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics

Published:2006-03 Issue:1 Volume:19 Page:10-32
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Blaney Joseph E.¹,Durbin Anna P.²,Murphy Brian R.¹,Whitehead Stephen S.¹

Affiliation:

1. Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

2. Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2006.19.10

Reference83 articles.

1. Accelerating the development and introduction of a dengue vaccine for poor children, 5?8 December 2001, Ho Chi Minh City, VietNam

2. Role of RNA structures present at the 3′UTR of dengue virus on translation, RNA synthesis, and viral replication

3. GENETICALLY MODIFIED, LIVE ATTENUATED DENGUE VIRUS TYPE 3 VACCINE CANDIDATES

4. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

5. Chemical Mutagenesis of Dengue Virus Type 4 Yields Mutant Viruses Which Are Temperature Sensitive in Vero Cells or Human Liver Cells and Attenuated in Mice

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally Transmitted Dengue Fever in Iran: A Growing Concern;Archives of Clinical Infectious Diseases;2024-09-08

2. Trends and insights in dengue virus research globally: a bibliometric analysis (1995–2023);Journal of Translational Medicine;2024-09-03

3. Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil;The Lancet Infectious Diseases;2024-08

4. The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics;Vaccines;2024-08-01

5. Subgenomic flavivirus RNA as key target for live-attenuated vaccine development;Journal of Virology;2024-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3